Two patients died during the transplant procedure. Ten of 12 evaluable patients were PCR positive in the BM for bcl-2 rearrangement at diagnosis. Six of them (60%) were still positive after chemotherapy, and one patient was transplanted with a positive hematopoietic product after purging. With ...
Autologous Peripheral Stem-Cell Transplantation autologous protein Autologous Serum Eye Drops autologous serum skin test Autologous Skeletal Muscle Grafts autologous sling procedure autologous stem cell rescue Autologous Stem Cell Transplant autologous stem cell transplantation ...
In an autologous stem cell transplant, bone marrow stem cells are removed from the patient’s own body prior to cancer treatment in order to protect them. Stem cells can be collected in two ways. The primary method involves collection of stem cells from the peripheral blood. For this procedu...
The prognosis for patients with central nervous system (CNS) involvement by recurrent or refractory diffuse large B-cell lymphoma is poor, with overall survival (OS) of 410 months. High-dose chemotherapy (HDC) and autologous stem cell transplant (ASCT) is a potential treatment alternative. We re...
Although autologous stem cell transplantation has modified the prognosis of myeloma, almost all patients still relapse some time after a single transplant, and then another therapeutic approach becomes necessary. With the aim of improving the results in the treatment of myeloma, new approaches including...
Again, it is unclear to what extent the reduction in new MRI lesions relates to the transplant procedure rather than the profound degree of immunosuppression associated with induction. In the trial reported by Nash et al (2003), death from post-transplantation lymphoproliferative disorder was ...
Here, the results seem to be practically identical and to the advantage of the auto/RICallo procedure. Although our report and the Italian study indicate better outcome with the auto/RIC allo transplant procedure than with only auto transplantation and no study has shown worse outcome with the ...
Thirty-two patients < 55 year with AML in first complete remission underwent autologous peripheral blood stem cell transplantation (PBSCT). Before transplant, they were treated with one or two induction courses plus one consolidation cycle including daunorubicin and araC. Thereafter, haemopoietic stem c...
Autologous hematopoietic stem cell transplant conditioning regimens for the treatment of severe autoimmune diseases. In: Dicke KA, Keating A (eds). Autologous Blood and Marrow Transplantation. Proceedings of the Ninth international Symposium. Carden Jennings Publishing: Arlington, Texas, Charlottesville, ...
A retrospective analysis on patients with diagnosis of peripheral T-cell lymphoma receiving autologous stem cell transplant was conducted (January 1997 to July 2008). The patients were stratified according to their International Prognostic Index (IPI), disease status at the time of transplant and ...